CD8A and neoplasm: Strategies including ICB, co-stimulatory receptor activation, transcription factor-based therapy, epigenetic therapy, metabolism-based therapy and cytokine therapy, have been reported to significantly improve CD8+ TEXs and boost anti-tumor immunity (5, 18, 39, 42, 44).